Nonprostanoid endothelium-derived factors inhibit renin release

Area of Science:

• Nephrology
• Endocrinology
• Vascular Biology

Background:

• Endothelium-derived prostaglandin I2 stimulates renin release.
• Exogenous endothelium-derived relaxing factor (EDRF) inhibits renin release.
• The role of EDRF as an endogenous regulator of renin release requires characterization.

Purpose of the Study:

• To investigate the role of EDRF in regulating renin release.
• To determine if EDRF production influences basal and stimulated renin release.
• To explore the contribution of EDRF to the effects of endothelin-1 on renin release.

Main Methods:

• Rat renal cortical slices were used for in vitro experiments.
• EDRF production was inhibited using NG-Monomethyl-L-arginine (LNMMA) or stimulated with L-arginine.
• Renin concentration was measured by radioimmunoassay for angiotensin I (Ang I) generation.
• Effects of isoproterenol, nitroprusside, melittin, and endothelin-1 on renin release were assessed.

Main Results:

• Inhibition of EDRF formation by LNMMA significantly enhanced basal renin release by over 50%.
• LNMMA did not alter isoproterenol-stimulated renin release, while L-arginine blocked this stimulation.
• Nitroprusside reversed melittin-stimulated renin release.
• Endothelin-1's inhibition of renin release was not affected by EDRF inhibition, indicating EDRF is not the sole mediator.

Conclusions:

• EDRF acts as an endogenous inhibitor of renin release.
• The interplay between EDRF, prostaglandins, and renin release is complex.
• Endothelin-1 inhibits renin release through mechanisms independent of EDRF stimulation.